Arvinas, Inc. (ARVN)
8.275
-0.04
(-0.42%)
USD |
NASDAQ |
Sep 18, 16:00
8.275
0.00 (0.00%)
After-Hours: 20:00
Arvinas Free Cash Flow : -208.80M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -208.80M |
| March 31, 2026 | -256.90M |
| December 31, 2025 | -275.70M |
| September 30, 2025 | -329.50M |
| June 30, 2025 | -399.00M |
| March 31, 2025 | -252.80M |
| December 31, 2024 | -261.10M |
| September 30, 2024 | -259.90M |
| June 30, 2024 | -217.10M |
| March 31, 2024 | -356.00M |
| December 31, 2023 | -350.70M |
| September 30, 2023 | -339.80M |
| June 30, 2023 | -322.70M |
| March 31, 2023 | -313.40M |
| December 31, 2022 | -280.30M |
| September 30, 2022 | -245.65M |
| June 30, 2022 | 503.33M |
| March 31, 2022 | 535.46M |
| Date | Value |
|---|---|
| December 31, 2021 | 554.70M |
| September 30, 2021 | 561.47M |
| June 30, 2021 | -142.50M |
| March 31, 2021 | -117.85M |
| December 31, 2020 | -96.20M |
| September 30, 2020 | -83.30M |
| June 30, 2020 | -58.84M |
| March 31, 2020 | -52.07M |
| December 31, 2019 | -46.87M |
| September 30, 2019 | -41.78M |
| June 30, 2019 | -54.37M |
| March 31, 2019 | -50.72M |
| December 31, 2018 | -18.95M |
| September 30, 2018 | 21.65M |
| June 30, 2018 | 26.14M |
| March 31, 2018 | 30.32M |
| December 31, 2017 | 4.101M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cocrystal Pharma, Inc. | -8.276M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | -66.14M |
| Definium Therapeutics, Inc. | -166.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -48.30M |
| Cash from Investing (Quarterly) | 54.90M |
| Cash from Financing (Quarterly) | 0.40M |
| Free Cash Flow Per Share (Quarterly) | -0.7382 |
| Free Cash Flow to Equity (Quarterly) | -48.10M |
| Free Cash Flow to Firm (Quarterly) | -48.50M |
| Free Cash Flow Yield | -37.69% |